Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Breast Adjuvant Escalation

Kathy Albain

MD

🏢Loyola University Medical Center🌐USA

Professor of Medicine

80
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kathy Albain is a SWOG investigator and leader in breast cancer adjuvant therapy research. She contributed to the TAILORx and RxPONDER studies defining the role of chemotherapy by Oncotype DX recurrence score. Her work has influenced adjuvant de escalation and escalation decisions. She is also a leader in health equity research in oncology.

Share:

🧪Research Fields 研究领域

breast cancer
adjuvant chemotherapy
Oncotype DX
clinical trials
health equity

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kathy Albain 的研究动态

Follow Kathy Albain's research updates

留下邮箱,当我们发布与 Kathy Albain(Loyola University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment